(MENAFN- EIN Presswire)
Looking forward, IMARC Group expects the global oncology APIs market to continue its strong growth during the next five years.
SHERIDAN, WYOMING, UNITED STATES, August 27, 2021 /EINPresswire.com / -- According to IMARC Group's latest report, titled“Oncology Active Pharmaceutical Ingredients (APIs) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026” the global oncology active pharmaceutical ingredients (APIs) market exhibited strong growth during 2021-2026. Oncology active pharmaceutical ingredient (API) refers to a combination of biologically active substances used in anti-cancer drugs. Some of the common elements of oncology API include alkylating agents, antimetabolites, cytotoxic, hormones, and signal transduction inhibitors. These ingredients are effective in investigating, diagnosing, treating, and preventing the growth of malignant diseases. Oncology APIs aim to destroy cancer cells without harming normal cells.
Request for a PDF sample of this report:
The increasing prevalence of cancer and rising concerns regarding the harmful side-effects of chemotherapy as an anti-cancer treatment are majorly driving the global oncology APIs market. Additionally, extensive research and development (R & D) activities in the study of tumors and improving the efficiency of various APIs to target cancer cells are further supporting the market growth. Apart from this, rising investments across the pharmaceutical industry for the discovery and the development of efficient anti-cancer drugs is creating a positive outlook for the market. Looking forward, IMARC Group expects the global oncology APIs market to continue its strong growth during the next five years.
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviors of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
Market Segmentation:
Breakup by Drug Type:
Innovative Oncology APIs
Generic Oncology APIs
Breakup by Manufacturer Type:
Captive Manufacturers
Merchant Manufacturers
Breakup by Type of Synthesis
Synthetic Oncology APIs
Biotech Oncology APIs
Breakup by Indication:
Lung Cancer
Breast Cancer
Colorectal Cancer
Prostate Cancer
Stomach Cancer
Liver Cancer
Esophagus Cancer
Cervical Cancer
Others
Breakup by Region:
North America (United States, Canada)
Europe (Germany, France, United Kingdom, Italy, Spain, Others)
Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Others)
Ask Analyst for Customization and Explore full report with TOC & List of Figures:
We are updating our reports, If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.
Key highlights of the report:
Market Performance (2015-2020)
Market Outlook (2021-2026)
Market Trends
Market Drivers and Success Factors
The Impact of COVID-19 on the Global Market
Value Chain Analysis
Structure of the Global Market
Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
Related Reports by IMARC Group:
Connected Drug Delivery Devices Market:
Apoptosis Assay Market:
Complementary and Alternative Medicine Market:
Catheters Market:
Trauma Care Centers Market:
Laboratory Proficiency Testing Market:
Extracorporeal Membrane Oxygenation Machine Market:
Medical Tapes and Bandages Market:
Oligonucleotide Synthesis Market:
Surgical Microscopes Market:
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, and nanotechnology industries. We also provide cost model and manufacturing setup project reports through Syndicated Analytics, a subsidiary of IMARC Group.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Elena Anderson
IMARC Services Private Limited
+ +1 6317911145
email us here
MENAFN27082021003118003196ID1102690022
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.